XML 35 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended 129 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Cash flows from operating activities:      
Net income/(loss) for the period $ (29,459) $ 54,620 $ (54,113)
Adjustments to reconcile net income/(loss) for the period to net cash used in operations:      
Depreciation and amortization 391 247 1,731
Stock-based compensation 3,036 1,363 10,096
Gain on disposal of marketable securities (145) (445) (7,947)
Loss on extinguishment of convertible notes     1,218
Accrued interest and accretion of interest   120 4,096
Gain on disposal of mineral property (1,934) (78,072) (81,867)
Common stock issued for interest     1,841
Unrealized (gain)/loss on other investments 13,184 (27,762) (24,163)
Write down of marketable securities     1,007
Deferred tax (benefit)/expense (6,276) 33,546 29,246
Other non-cash items     1,304
Change in working capital account items:      
Other current assets (590) (33) (2,029)
Accrued interest payable   (504) (8,090)
Accounts payable, accrued liabilities and other (1,402) 295 (487)
Net cash used in operating activities (23,195) (16,625) (128,157)
Cash flows from investing activities:      
Purchases of marketable securities (138) (267) (1,826)
Proceeds from sales of marketable securities 248 583 11,297
Acquisition of long-term investments   (3,632) (3,632)
Additions to mineral property   (588) (7,647)
Additions to plant and equipment (861) (255) (21,304)
Change in restricted cash 75   75
Proceeds from additional option agreement 2,500 1,000 3,500
Proceeds from earn-in right agreement 2,000   2,000
Proceeds on disposal of mineral property     188
Proceeds on disposal of plant and equipment     52
Cash transferred to Allied Nevada Gold Corp., net of receivable     (24,517)
Net cash (used in)/provided by investing activities 3,824 (3,159) (41,814)
Cash flows from financing activities:      
Net proceeds from equity financings 14,231 28,984 151,301
Repayment of convertible notes   (23,000) (26,108)
Proceeds from exercise of warrants 1,365 309 40,694
Proceeds from exercise of compensation options 733   733
Proceeds from exercise of stock options 21 706 3,995
Issuance of convertible notes     28,345
Cash paid in lieu of capital stock issuances   (107) (107)
Transaction costs     (1,841)
Net cash provided by financing activities 16,350 6,892 197,012
Increase/(decrease) in cash and cash equivalents (3,021) (12,892) 27,041
Decrease in cash and cash equivalents - discontinued operations     (12,863)
Net increase/(decrease) in cash and cash equivalents (3,021) (12,892) 14,178
Cash and cash equivalents, beginning of period 17,873 39,838 674
Cash and cash equivalents, end of period $ 14,852 $ 26,946 $ 14,852